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adopts the approach of using a minimum data set to model outcome and has been previously
shown to be feasible after index arterial operations. This study attempts to model mortality
following lower limb amputation for critical limb ischaemia using the VBHOM concept.
Methods: A binary logistic regression model of risk of mortality was built using National
Vascular Database items that contained the complete data required by the model from 269
admissions for lower limb amputation. The subset of NVD data items used were urea, creati-
nine, sodium, potassium, haemoglobin, white cell count, age on and mode of admission. This
model was applied prospectively to a test set of data (nZ 269), which were not part of the
original training set to develop the predictor equation.
Results: Outcome following lower limb amputation could be described accurately using the
same model. The overall mean predicted risk of mortality was 32%, predicting 86 deaths.
Actual number of deaths was 86 (c2Z 8.05, 8 d.f., pZ 0.429; no evidence of lack of fit).
The model demonstrated adequate discrimination (c-indexZ 0.704).f Academic & Research Surgery (SARS), Cambridge, January 2007.
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VBHOM-based Outcome Model for Lower Limb Amputation 63Conclusions: VBHOM provides a single unified model that allows good prediction of surgical
mortality in this high risk group of individuals. It uses a small, simple and objective clinical
data set that may also simplify comparative audit within vascular surgery.
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Patients requiring lower limb amputation have a high
associated peri-operative risk with reported 30-day
mortality rates of up to 17%.1 The high mortality rates
observed in these patients are reflective of their multiple
co-morbidities. Subjecting patients with a high operative
risk to a futile operation has resource and ethical implica-
tions. Patient selection is usually dependent on the opinion
and experience of the consultant vascular surgeon in
conjunction with the anaesthetist. Therefore a scoring
system that could identify patients pre-operatively in
whom operative intervention would be unsuccessful would
be valuable, but a reliable tool has yet to be found. It would
be unjustifiable to deny a patient a potentially life-saving
operation based on an inaccurate predictive instrument. A
number of predictive factors associated with poor post-
operative outcome after lower extremity amputation has
been identified that could be used to stratify the operative
risk.2 These include female gender, congestive heart failure
and high-level amputation. Statistical models have been
built to accurately predict outcome after index arterial
operations3e5 but these have generally suffered from
incomplete data collection and have been too complex for
practical regular use.
VBHOM (Vascular Biochemistry and Haematology
Outcome Models) adopts a different approach of using
a minimum data set to model outcome and has been
previously shown to be feasible with index arterial oper-
ations.6e8 VBHOM uses only data items, which can be
obtained pre-operatively. They are logistically feasible to
collect from hospital pathology and patient administration
computer systems and they are collected routinely within
the normal pathways of clinical care. Importantly the
clinical data are precisely measurable, objective and
subject to the routine scrutiny of the hospital pathology
department. In theory, these data items should be available
for all patients. Therefore their application can be
universal and data collection is not an additional burden to
the staff providing care.
The aim of this study was to develop and validate a new
VBHOM equation for patients undergoing lower limb
amputation for critical ischaemia using data collected over
an 8-year period from three hospitals within East Anglia,
United Kingdom, of which one (Cambridge Vascular Unit) is
an academic regional teaching centre.
Methods and Patients
The new VBHOM model was built from data collected on the
National Vascular Database (NVD) amputation specific
database form (http://www.vascularsociety.org.uk/Docs/
Forms_VSGBI%20NVD%202006.pdf), from three hospitals
within the East Anglia region, United Kingdom. Recordscomprised of patients who underwent lower limb amputa-
tion for critical ischaemia from January 1998 to February
2006.
Indications for amputation were for dysvascularity
only, including peripheral vascular disease (PVD), acute
ischaemia, embolism and gangrene. A small number of
these amputations were performed for ischaemic pain
control and for long-standing non-healing ulceration.
Patients who had lower amputations for trauma or for
bone or lower limb tumours were excluded. Patients were
not offered surgery if the attending physician believed
that the patient would not survive an operative procedure
or if it was believed that the patient would have no
meaningful quality of life after surgery. The decision to
palliate was taken in consultation with the patient and
next of kin.
The following data items were extracted from the
database: discharge status of patient (alive or dead),
admission date and discharge date, age at admission, mode
of admission and gender. Haemoglobin, white cell count,
urea, sodium and potassium levels were used from the first
set of blood taken on admission or those taken immediately
pre-operatively. This was usually the sample taken on the
day before or on the day of surgery. The cases were then
ordered by dead/alive status at discharge (alive on
discharge from hospital. Many patients remain on medical
wards after amputation) and age at admission, and records
were then placed alternately into 2 data sets. In-hospital
mortality occurring later than 30 days after the operation
was also included in this. Splitting the data like this ensured
that there were equal numbers of deaths in both sets and
that the age range was similar in each group. Using data
from one as the training set, binary logistic regression
(SPSS version 11; SPSS, Chicago, Illinois, USA) was used to
form a model of adverse clinical outcome (mortality at
discharge).
The model was then applied prospectively to the
second (validation) set of patients whose data had not
been part of the original training set to develop the
predictor equation. It is important to have adequate
number of deaths in each set to model outcome using
logistic regression. Typically, as a rule at least 10 outcome
events per potential predictor variable are required to
minimise the risk of a Type I error.9
Case notes were analysed retrospectively for observed
in-hospital or 30 days of operation mortality.
Statistical Analysis
The overall performance of the model was assessed using
techniques designed to test both calibration and
discrimination.
The HosmereLemeshow10e13 methodology was followed
to assess the calibration of the model. This involves the use
Table 1 Mortality e model tested against training set
% Range
predicted
mortality
Number Mean %
predicted
risk
Predicted
deaths
Reported
deaths
c2
0.0e20.9 72 12.99 9 10 0.05
20.9e28.2 35 25.62 9 10 0.16
28.2e32.3 31 30.02 9 11 0.44
32.3e36.2 27 34.10 9 5 2.92
36.2e40.3 27 38.77 10 7 1.88
40.3e44 17 41.90 7 7 0.00
44e48 15 45..52 7 8 0.37
48e50 16 48.98 8 10 1.17
50e58 17 53.59 9 11 0.84
58e100 12 64.79 8 7 0.22
0e100 269 31.96 86 86 8.05
c2Z 8.05, 8 d.f., pZ 0.429; no evidence of lack of fit;
c-indexZ 0.704.
64 T.Y. Tang et al.of the chi-squared test to compare frequency tables
obtained from prospective application of the equations.
This is a null hypothesis test. A p value< 0.05 indicates
a significant lack of fit. While it is possible to say that
a model is wrong, i.e. did not predict outcome, it is not
possible to state that a particular model is correct, only
that it performed adequately.
The discriminative ability of the model was assessed
using the c-index (equivalent to the area under the recei-
vereoperator characteristic (ROC) curve. Discrimination is
the ability of the model to appropriately rank patients in
terms of risk e that is, the model’s ability to ascribe high
risks to high-risk patients and vice-versa. Values of 0.5 are
no better than chance. It is generally accepted that
reasonable models produce values in the range of 0.7e0.8
and good models give values 0.8e0.9.
The ability of the model to stratify risk was also
demonstrated (Tables 1 and 2). Episodes were grouped
within bands on the risk generated by the regression
equation. The risk bands were chosen to give at least five
predicted deaths in at least 80% of cases (Cochrane’s rule)
and to give, where possible, approximately equal predicted
numbers in each risk range.
Results
We collected 579 records but had to exclude 41 (7%) due to
incomplete documentation or lack of follow-up in the
immediate post-operative period. Therefore the data used
contained 538 complete records. The three hospitals
contributed 281, 163, 94 cases, respectively, with the
largest contribution from a tertiary referral teaching
hospital. The other two hospitals were district general
hospitals.
Binary logistic regression analysis of the laboratory and
administrative data of the training set (Table 1) produced
the following outcome model for lower limb amputations
for critical ischaemia:Table 2 Mortality e prospective application of the new
VBHOM model to validation set
% Range
predicted
mortality
Number Mean %
predicted
risk
Predicted
deaths
Reported
deaths
c2
0.0e20.1 77 12.11 9 11 0.34
20.1e27.5 39 24.02 9 8 0.26
27.5e32.9 31 30.20 9 15 4.87
32.9e37.7 27 35.02 9 9 0.03
37.7e41.4 21 39.29 8 6 1.01
41.4e45 18 42.95 8 9 0.37
45e49 17 46.64 8 8 0.00
49e55 15 51.72 8 4 3.77
55e64 14 59.70 8 9 0.12
64e100 10 72.72 7 6 0.82
0e100 269 31.53 85 85 11.60
c2Z 11.60, 10 d.f., pZ 0.313; no evidence of lack of fit;
c-indexZ 0.677.lnefR=ð1 RÞgZ3:495þ ð0:5942 genderÞ
þ ð1:069mode of admissionÞ
þ ð0:0119 age on admissionÞ þ 0:0319 ureafmmol=lg
þ  0:0432 sodiumfmmol=lgþ ð 0:0037
 potassiumfmmol=lgÞþ ð 0:1260 haemoglobinfg=dlgÞ
þ 0:0679white cell count 109=lþ ð 0:0004
 creatininefmmol=lgþ ð3:397 ðurea=creatinineÞÞ
RZ the risk of death.
Gender takes the value 1 for male and 0 for female.
Mode of admission takes the value 0 for elective and 1
for non-elective admissions.
It was found that the model could successfully describe
lower limb amputation mortality in the validation test set
(Table 2). The equation also performed adequately in terms
of discrimination.
Patient demographics are shown in Table 3.Discussion
The results of this study confirm that attempts at life-saving
lower limb amputation for critical ischaemia are frustrated
by a considerable rate of post-operative mortality (32%).
We accept that our mortality rate is higher than in other
series1,14,15 although the cohort of patients we used was
selective and from several centres. It may also indicate that
in some cases we were possibly too aggressive in our
surgical approach when conservative or palliative strategies
would have been more prudent. This calls for a better pre-
operative quantitative stratification of the operative risk as
well as identification of patients who may not benefit from
surgical intervention.
This observational study focussed on the development
and validation of a new VBHOM model addressing specifi-
cally post-operative mortality following lower extremity
amputation for critical ischaemia. It was built from data
Table 3 Patient demographics of patients (nZ 538)
Variable Number
Number 538
Median age (years) (range) 75 (37e96)
Male (%) 309 (57)
Female (%) 229 (43)
Mean haemoglobin ( SD) 11.9 (1.1)
Mean white cell count ( SD) 10.9 (1.4)
Mean serum sodium ( SD) 135 (4.5)
Mean serum potassium ( SD) 4.5 (0.68)
Mean serum urea ( SD) 9.8 (5.8)
Emergency admission (%) 386 (72)
AKA:BKA:other 314:211:13
Observed in-hospital mortality (%) 171 (32)
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East Anglian region of the United Kingdom. As demon-
strated, it provides a model that allows reasonable
prediction (c-indexZ 0.6e0.7) of surgical mortality and
validates previous work based on the VBHOM concept that
the risk of in-hospital mortality can be modelled in patients
undergoing index arterial operations such as AAA repair
using a small number of commonly used laboratory and
administrative items.6,8 One of the refinements made to
this model is the addition of creatinine to the predictor
equation. Previously urea was the only biochemical
measure of renal function on the National Vascular Data-
base (NVD) proforma. The use of creatinine clearance is
likely to be a better indicator of renal impairment than
urea alone.16
The ability to predict clinical outcomes from laboratory
measurements taken from a single venesection pre-opera-
tively would provide significant advantages. It could facili-
tate the optimal use of limited resources such as intensive
care by allowing focussed surveillance of high-risk patients
to be placed post-operatively in clinical areas capable of
close monitoring and early therapeutic intervention. It may
also allow the vascular surgeon to predict risk in an indi-
vidual patient before surgery and this risk can be discussed
confidently with both patient and relatives whilst gaining
informed consent. If the predicted risk assessment is too
high for a patient a less invasive procedure or conservative
management may be entertained. Other advantages of this
scoring system are that it is generally simple and applicable
to all admissions and it is usually possible to collect all the
items required as part of routine clinical care. Therefore it
makes no demands on the staff providing the care and all
that is necessary is access to the hospital information
systems to view to the results. The biochemical and hae-
matological data items are precisely measurable, objective
and are subject to the rigorous quality control processes
implemented by the hospital laboratories. Furthermore the
data required for predicting risk are likely to be available
very soon after admission, irrespective of the mode of
admission and the time of day.
The VBHOM approach was developed in response to
the difficulty of collecting all data items required by the
NVD on all patients in all centres submitting data to the
NVD. It is essentially a minimalist approach designed to
overcome the problem of missing data, which are theAchilles heel of all clinical data collection exercises.17
The VBHOM approach uses simple data that are possible
to collect pre-operatively on all patients. It does not use
any data collected at operation. All risk models can only
predict risk within the ‘‘dimensions’’ of the data items
used within the model. It is certain that there are
numerous other factors, many of which would only be
found at operation, which influence the risk of adverse
outcome for individual patients. Besides co-morbidities,
a multidisciplinary approach, referral pathway and
revascularization policy have an important impact on
the outcome of these patients18,19 but taking into
consideration of these factors would lead to a compli-
cated score, which would be difficult to use and
implement universally. Furthermore cardiac disease is an
important predictor of outcome but this is not used by
VBHOM and despite this the model performs well. The
haematological and biochemistry results may in fact
be a surrogate marker for cardiac disease. For example,
a high urea or low haemoglobin level may act as a
surrogate marker for renal failure and cardiac disease,
respectively.
This study did not include patients who were deemed
unfit for amputation and were therefore palliated. The
operative mortality is high but without surgery death was
inevitable. It is often difficult to deny sick patients surgery
if they understand death is the alternative. A prospective
study would help to delineate this further.
Limitations of the study include the fact that retro-
spective data was used not only to generate but also to
validate the model. Since 2006, lower extremity amputa-
tion has become one of the index arterial operations for
which the Vascular Society of Great Britain and Ireland
collects data on20 and hence this new VBHOM model should
not be taken as a definitive predictor equation. It will
require refinement and is likely to evolve as knowledge
increases and the NVD expands. It should be possible to
validate the predictor equations generated in this study
against data submitted to the NVD in the near future.
However, although this approach may be generally appli-
cable it should be further tested in other geographical
locations before it is used to influence patient
management.
Another limitation is that the data were collected from
three hospitals. The baseline characteristics of the patients
that were admitted may have been different, and it is
possible that the model did not fully adjust for differences
in these patient characteristics e.g. one hospital could
treat mainly diabetics, the other patients in haemodialysis.
Therefore, the training group and the validating group
could be different by means of risk factors and the indi-
cations for amputation (CLI, embolism or Buerger’s disease
do not have the same risk). However, patients were
assigned to the training and validation sets randomly and
we have no reason to believe that the groups were
different.Conclusions
VBHOM provides a single unified model that allows reason-
able prediction of surgical mortality after lower limb
66 T.Y. Tang et al.amputation for critical ischaemia. It may be useful to
simplify comparative audit but will need greater refine-
ment and validation before it can be used reliably for risk
prediction in an individual patient before surgery.
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